Work

Pharmacological mechanisms of norcantharidin against hepatocellular carcinoma.

Year: 2023
Type: article
Abstract: and CDC25C, and by inhibiting the c-Met-mTOR and JAK/STAT3 signaling pathways, reversing the methylation of RASSF1A gene, and activating TRAIL-R2/DR5 signal transduction.
Authors: Zhong-Ming Qian, Yun-Jin Chen, Yu-Xin Bao
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W4389452483
FWCI: 1.32
Cites: 131
Cited by: 16
Related to: 9